Literature DB >> 10696862

Exposure to formaldehyde and phenol during an anatomy dissecting course: sensitizing potency of formaldehyde in medical students.

F Wantke1, M Focke, W Hemmer, R Bracun, S Wolf-Abdolvahab, M Götz, R Jarisch, M Götz, M Tschabitscher, M Gann, P Tappler.   

Abstract

BACKGROUND: The sensitizing potency of formaldehyde and phenol during anatomy dissecting was investigated. The objective was to determine whether exposure induces specific IgE or IgG against formaldehyde-albumin or phenol-albumin.
METHODS: In 27 medical students, specific IgE against formaldehyde-albumin by RAST plus ELISA and specific IgE against phenol-albumin by ELISA were assessed. In addition, specific IgG against formaldehyde-albumin was assessed in 23 students. Symptoms before and during dissecting were assessed, and indoor formaldehyde and phenol were measured.
RESULTS: Mean indoor formaldehyde was 0.265 +/- 0.07 mg/m3, and mean indoor phenol was 4.65 +/- 2.96 mg/m3. Specific IgE/IgG against formaldehyde-albumin was not found at the beginning. Four students developed specific IgE against formaldehyde-albumin (RAST classes of > or =2.0), and all four also had specific IgE in the ELISA, but IgG against formaldehyde-albumin was not found. Specific IgE against phenol-albumin was not seen. Itch and paresthesia of the hands (P<0.00001), dizziness (P<0.008), burning eyes (P<0.01), headache, sneezing, epistaxis, gingival bleeding, oral or pharyngeal itch, and shortness of breath were experienced.
CONCLUSIONS: Formaldehyde exposure during dissecting may induce specific IgE, but not IgG, against formaldehyde-albumin. Sensitization did not correlate with symptoms.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10696862     DOI: 10.1034/j.1398-9995.2000.00307.x

Source DB:  PubMed          Journal:  Allergy        ISSN: 0105-4538            Impact factor:   13.146


  13 in total

Review 1.  The TRPA1 channel in migraine mechanism and treatment.

Authors:  S Benemei; C Fusi; Gabriela Trevisan; Pierangelo Geppetti
Journal:  Br J Pharmacol       Date:  2014-05       Impact factor: 8.739

2.  Formaldehyde in the indoor environment.

Authors:  Tunga Salthammer; Sibel Mentese; Rainer Marutzky
Journal:  Chem Rev       Date:  2010-04-14       Impact factor: 60.622

3.  Occupational exposure to formaldehyde in an institute of morphology in Brazil: a comparison of area and personal sampling.

Authors:  Soraya de M Ochs; Lucas de O Grotz; Luciara S Factorine; Mauro R Rodrigues; Annibal D Pereira Netto
Journal:  Environ Sci Pollut Res Int       Date:  2012-02-10       Impact factor: 4.223

4.  Changes in subjective symptoms and allergy state among medical students exposed to low-level formaldehyde 6 months after completion of a gross anatomy dissection course.

Authors:  Mihoko Mori; Michiko Hoshiko; Kunio Hara; Tsuyoshi Saga; Kouichi Yamaki; Tatsuya Ishitake
Journal:  Environ Health Prev Med       Date:  2013-04-16       Impact factor: 3.674

5.  Formaldehyde exposure in gross anatomy laboratory of Suranaree University of Technology: a comparison of area and personal sampling.

Authors:  Naruwan Saowakon; Piyada Ngernsoungnern; Pornpun Watcharavitoon; Apichart Ngernsoungnern; Rachain Kosanlavit
Journal:  Environ Sci Pollut Res Int       Date:  2015-08-02       Impact factor: 4.223

Review 6.  Ion channels and migraine.

Authors:  Jin Yan; Gregory Dussor
Journal:  Headache       Date:  2014-04       Impact factor: 5.887

7.  Comparison of subjective symptoms associated with exposure to low levels of formaldehyde between students enrolled and not enrolled in a gross anatomy course.

Authors:  Mihoko Mori; Yuuki Matsumoto; Nanae Kushino; Yoshitaka Morimatsu; Michiko Hoshiko; Tsuyoshi Saga; Koh-ichi Yamaki; Tatsuya Ishitake
Journal:  Environ Health Prev Med       Date:  2015-10-26       Impact factor: 3.674

Review 8.  Antidromic vasodilatation and the migraine mechanism.

Authors:  Pierangelo Geppetti; Eleonora Rossi; Alberto Chiarugi; Silvia Benemei
Journal:  J Headache Pain       Date:  2011-12-27       Impact factor: 7.277

Review 9.  Targeting TRP channels for novel migraine therapeutics.

Authors:  Gregory Dussor; J Yan; Jennifer Y Xie; Michael H Ossipov; David W Dodick; Frank Porreca
Journal:  ACS Chem Neurosci       Date:  2014-08-29       Impact factor: 4.418

Review 10.  TRPA1 and other TRP channels in migraine.

Authors:  Silvia Benemei; Francesco De Cesaris; Camilla Fusi; Eleonora Rossi; Chiara Lupi; Pierangelo Geppetti
Journal:  J Headache Pain       Date:  2013-08-13       Impact factor: 7.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.